{
    "2018-05-04": [
        [
            {
                "time": "2018-04-27",
                "original_text": "Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah's 2nd Indication",
                "features": {
                    "keywords": [
                        "Pharma",
                        "MRK",
                        "PFE",
                        "FDA",
                        "Kymriah"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-28",
                "original_text": "How Much Upside Does Esperion Therapeutics Offer?",
                "features": {
                    "keywords": [
                        "Esperion",
                        "Therapeutics",
                        "Upside"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-29",
                "original_text": "Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah's 2nd Indication",
                "features": {
                    "keywords": [
                        "Pharma",
                        "MRK",
                        "PFE",
                        "FDA",
                        "Kymriah"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-01",
                "original_text": "As the Dow soars, technician names Apple, and two others as stocks to watch",
                "features": {
                    "keywords": [
                        "Dow",
                        "soars",
                        "Apple",
                        "stocks",
                        "watch"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Allergan’s Business Segments in 1Q18",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Business",
                        "Segments",
                        "1Q18"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-03",
                "original_text": "Q1 Earnings Drag Pharma ETFs Down",
                "features": {
                    "keywords": [
                        "Q1",
                        "Earnings",
                        "Pharma",
                        "ETFs",
                        "Down"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-04",
                "original_text": "10 Blue-Chip Stocks That Warren Buffett Dumped (And Why)",
                "features": {
                    "keywords": [
                        "Blue-Chip",
                        "Warren",
                        "Buffett",
                        "Dumped"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-05",
                "original_text": "Analyzing the Cash Flows and Valuation Metrics of Akorn",
                "features": {
                    "keywords": [
                        "Cash",
                        "Flows",
                        "Valuation",
                        "Metrics",
                        "Akorn"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-06",
                "original_text": "Why Geron Corporation Stock Sank Last Month",
                "features": {
                    "keywords": [
                        "Geron",
                        "Corporation",
                        "Stock",
                        "Sank"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-07",
                "original_text": "OEF, JPM, JNJ, UNH: Large Outflows Detected at ETF",
                "features": {
                    "keywords": [
                        "OEF",
                        "JPM",
                        "JNJ",
                        "UNH",
                        "Outflows",
                        "ETF"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "financials",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-08",
                "original_text": "Abbott’s Freestyle Libre CGM’s Performance, Growth Prospects",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Freestyle",
                        "Libre",
                        "CGM",
                        "Performance",
                        "Growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-09",
                "original_text": "How Analysts View Amgen",
                "features": {
                    "keywords": [
                        "Analysts",
                        "View",
                        "Amgen"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}